ArticleScience progress
The clinical utility of the immune status questionnaire as a marker of immune function among persons with schizophrenia.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Imbalance of the Brain-Gut-Microbiota Axis in Major Depressive Disorder: From Pathogenesis to Clinical Translation.Neuropsychiatric disease and treatment · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveImmune-inflammatory dysregulation contributes to the pathophysiology of schizophrenia and other chronic disorders. Interleukin-6 (IL-6) and C-reactive protein (CRP) are established inflammatory biomarkers, yet their blood-based assessments are costly, time-consuming, and invasive. The Immune Status Questionnaire (ISQ), a brief self-report measure, may offer a noninvasive alternative for identifying individuals who require further immune evaluation. This study examined the associations among ISQ, IL-6, CRP, and physiological factors in patients with schizophrenia.MethodsThis retrospective chart review included 94 patients with schizophrenia, among whom 74 completed both blood sampling and the ISQ assessment. Hierarchical linear regression and structural equation modeling (SEM) were used to examine associations between immune markers and physiological variables.ResultsISQ and cholesterol significantly predicted CRP levels, whereas IL-6 and cholesterol remained significant in the final regression model. SEM confirmed these pathways, showing that age, ISQ, and cholesterol influenced CRP through IL-6 mediation. Receiver operating characteristic (ROC) analyses identified an ISQ cutoff score of 10 and an IL-6 threshold of 3.0 pg/mL, yielding an area under the curve of 0.59 and a negative predictive value of 72.2%.ConclusionsThe ISQ demonstrates modest but practical potential as a noninvasive preliminary screening tool for immune dysfunction in schizophrenia. Given its accessibility and low cost, the ISQ may complement laboratory testing during early clinical evaluation. However, due to the limited sample size and retrospective design, further large-scale, community-based studies are warranted to validate its reliability, discriminative ability, and broader clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.